Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Insuman Implantable in type 1 diabetes patients with Medtronic MiniMed implantable pump
NL-OMON37980Phase 3Active, not recruiting
- Sponsor
- Sanofi
- Start
- May 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Sanofi. Primary endpoint: Primary safety and efficacy endpoint. Started May 2011; status: active, not recruiting.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on NL-OMON37980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37980.